4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-075407
Chief Executive Officer sold 2,333 shares at $0.92 ($2,146)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2023-06-27 | Sale | −2,333 | $0.92 | $2,146 | 3,519 | D |
| Open-market sales · 2,333 sh · avg $0.92 · $2,146 | |||||||
Loading xslF345X04/tm2317417-5_4seq1.xml…